03347 TIGERMED
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 2.18X | Oper Margin | 13.2% |
|---|---|---|---|
| LT Debt/Equity | 4.6% | Net Margin | 13.0% |
| Total Debt/Equity | 7.1% | Return on Equity | 4.2% |
| Price/Book | 1.57X | Return on Assets | 3.1% |
| (HKD 42.700) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 988.31 | 430.87 | 2,233.62 | 2,260.44 | 3,519.93 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +129.4 | -80.7 | -1.2 | -35.8 | +69.5 |
| Earnings Per Share (HKD) | 1.155 | 0.499 | 2.582 | 2.614 | 4.066 |
| Earnings Per Share Growth (%) | +131.3 | -80.7 | -1.2 | -35.7 | +55.4 |
| Dividend Per Share (HKD) | 0.140 | 0.325 | 0.624 | 0.616 | 0.580 |
| P/E* (X) | 36.98 | 85.54 | 16.54 | 16.33 | 10.50 |
| Yield (%) | 0.33 | 0.76 | 1.46 | 1.44 | 1.36 |
| Dividend Share (%) | 12.15 | 65.00 | 24.15 | 23.55 | 14.25 |
| Book NAV (HKD) | 27.282 | 25.524 | 26.618 | 25.226 | 25.495 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 6,833 | 6,603 | +3.5 | 7,384 |
| Operating Result | 807.263 | 629.585 | +28.2 | 2,384 |
| Associates | 198.507 | 31.271 | +534.8 | 105.183 |
| Profit Before Taxation | 1,003 | 664.462 | +50.9 | 2,490 |
| Taxation | 198.159 | 216.63 | -8.5 | 338.606 |
| Profit /( Loss) After Taxation | 805.056 | 447.832 | +79.8 | 2,152 |
| Minority Interests | -82.834 | 42.688 | -294.0 | 125.078 |
| Net Profit | 887.89 | 405.143 | +119.2 | 2,027 |
| Earnings Per Share () | 1.1547 | 0.4992 | +131.3 | 2.5824 |
| Dividend Per Share () | 0.1403 | 0.3245 | -56.8 | 0.6237 |
| Announcement Date | 2026-03-30 | 2025-03-27 | NA | 2024-03-28 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
